ASTCT Talks
By ASTCT
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by ASTCT
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 71
Description
ASTCT Talks is the official podcast of the American Society for Transplantation and Cellular Therapy (ASTCT). We chat with industry leaders from all areas of the blood and marrow transplantation and cellular therapy field, including doctors, physician assistants, pharmacists, nurses, administrators, social workers, and more. We hope you enjoy listening!
| Episode | Date |
|---|---|
|
Treatment Options for cGVHD: Adult vs. Pediatric Perspectives
|
Mar 31, 2026 |
|
Best Practice Considerations for Infection Prevention and Management Post-CAR T
|
Jan 13, 2026 |
|
LIVE From ASH: Multiple Myeloma Treatment Redefined by Bispecific Antibodies and T-Cell Therapies
|
Jan 06, 2026 |
|
What Clinicians Need to Know About Chronic GVHD and Immunity
|
Dec 16, 2025 |
|
Pulmonary Manifestations of Chronic GVHD
|
Dec 16, 2025 |
|
Tackling Cognitive Challenges in Survivorship Care
|
Dec 02, 2025 |
|
Titans of Transplant: Innovations in CAR T Cell Therapy
|
Oct 24, 2025 |
|
Pharmacist Takeover: BCMA Bispecifics and CAR T-Cell Therapy
|
Oct 16, 2025 |
|
Optimizing Care for TILs, Cellular Therapy in Melanoma and Solid Tumors
|
Oct 09, 2025 |
|
Cord Blood Transplantation: Past, Present and Future Innovations
|
Oct 02, 2025 |
|
Managing Mental Health in Chronic GVHD
|
Sep 12, 2025 |
|
Physician-Patient Communication in the Post-Transplant Setting
|
Aug 05, 2025 |
|
Delayed Neurotoxicity With Car-T Therapy in Myeloma: What Clinicians Need To Know
|
Jul 17, 2025 |
|
Titans of Transplant: Dr. Daniel Weisdorf
|
Jun 25, 2025 |
|
CAR T and Transplantation Advances Across Hematologic Cancers at ASCO 2025
|
Jun 16, 2025 |
|
Homegrown CAR-T: Expanding Access Through Academic Innovation
|
Jun 04, 2025 |
|
Rethinking Tacrolimus Targets in the PTCy Era
|
May 19, 2025 |
|
Reviewing Real-World Use of Beti-Cel in Transfusion-Dependent β-Thalassemia
|
May 05, 2025 |
|
Key CAR T and Transplantation Presentations From The 2025 Tandem Meeting
|
Apr 24, 2025 |
|
Understanding Cutaneous GVHD: Clinical Insights and Care Strategies
|
Apr 18, 2025 |
|
The Role of Lifestyle Medicine in Chronic GVHD with Dr. Steven Pavletic
|
Feb 13, 2025 |
|
Optimizing Graft Selection: A New Era in Transplantation with Dr. Lori Muffly
|
Jan 22, 2025 |
|
Oral Chronic Graft-Versus-Host Disease and Oral Health After Allogeneic Hematopoietic Cell Transplantation — What the Care Team Needs To Know
|
Dec 11, 2024 |
|
Titans of Transplant: Dr. Renier Brentjens
|
Nov 12, 2024 |
|
Understanding Ocular Graft-versus-Host Disease to Facilitate an Integrated Multidisciplinary Approach
|
Oct 29, 2024 |
|
Leveraging Ex Vivo Gene Therapy Advancements in Hemoglobinopathies and Metabolic Diseases
|
Oct 22, 2024 |
|
Outpatient CAR T: Navigating Logistics and Patient Care
|
Oct 14, 2024 |
|
Bridging the Gap: Addressing Disparities in GVHD Care
|
Sep 25, 2024 |
|
Managing Secondary Cancer Risks After CAR T-Cell Therapy in Multiple Myeloma Subgroups
|
Sep 03, 2024 |
|
Exploring Insights From CAR-TITUDE 4 and KarMMa-3 Trials with Dr. Jens Hillengass
|
Jul 20, 2024 |
|
A New Era in GVHD Prophylaxis: A Conversation With Dr. Samer Al-Homsi
|
Jun 24, 2024 |
|
Beyond Remission: Navigating the Late Effects of Pediatric CAR T-Cell Therapy
|
Apr 29, 2024 |
|
A Conversation with Mike Niles: Author of ‘Hard Graft: Our Fight Against Killer Blood’
|
Feb 12, 2024 |
|
Titans of Transplant: Dr. Stephanie Lee
|
Jan 16, 2024 |
|
Exploring the BMT CTN 1703 Study
|
Dec 04, 2023 |
|
Navigating CAR-T Survivorship
|
Nov 28, 2023 |
|
Beyond BCMA: Exploring Talquetamab in Myeloma Therapy
|
Nov 15, 2023 |
|
Behind the Scenes of CAR-T Therapy at University of California, Davis
|
Nov 01, 2023 |
|
Revitalizar, Prosperar y Sobrevivir: El Poder del Movimiento en la Recuperación de los Trasplantes
|
Oct 16, 2023 |
|
Revitalize, Thrive, and Survive: The Power of Movement in Transplant Recovery
|
Oct 16, 2023 |
|
A PTCy of Relief: GVHD Prophylaxis in Matched Unrelated Donors
|
Oct 12, 2023 |
|
Navigating Intersectionality in GVHD and Transplant Medicine
|
Sep 28, 2023 |
|
Advancing ALL Treatment and Insights on MRD Monitoring
|
Sep 18, 2023 |
|
Monitoring After CAR-T Therapy for Multiple Myeloma: The APP Perspective
|
Aug 18, 2023 |
|
Titans of Transplant: Dr. Rick Jones
|
Jul 17, 2023 |
|
Breaking Barriers and Dispelling Misconceptions in Transplantation
|
Jun 20, 2023 |
|
How to Handle CAR-T Waitlists in Multiple Myeloma
|
May 18, 2023 |
|
Treating Cytopenias After CAR T-cell Therapy
|
May 05, 2023 |
|
Bispecific Antibodies in Myeloma: The Who, What, When, and Where
|
Apr 18, 2023 |
|
Virus-Specific T-Cells (VST): Where We Are and How We Got Here
|
Apr 06, 2023 |
|
Titans of Transplant: Dr. Micah Skeens
|
Mar 15, 2023 |
|
MRD in Relation to Transplantation and Cell Therapy
|
Feb 07, 2023 |
|
The Winter "Tridemic" in Cellular Therapy
|
Jan 11, 2023 |
|
Titans of Transplant: Susan Slater, MN, FNP-BC
|
Dec 07, 2022 |
|
Monkeypox in HCT and CAR T
|
Oct 26, 2022 |
|
Titans of Transplant: Dr. John F. DiPersio
|
Oct 10, 2022 |
|
Celebrating Advocacy Efforts, Overcoming Barriers and Addressing Inequity in Cellular Transplantation
|
Sep 28, 2022 |
|
Titans of Transplant: Dr. Rainer Storb
|
Sep 13, 2022 |
|
Titans of Transplant: Dr. Adriana Seber
|
Jul 12, 2022 |
|
Finding Affordable and Accessible Hematopoietic Cell Transplants
|
Jun 29, 2022 |
|
Titans of Transplant: Dr. Krishna Komanduri
|
Apr 04, 2022 |
|
Managing COVID-19 in Transplant Patients
|
Mar 16, 2022 |
|
Titans of Transplant: Dr. Gregorio Jaimovich
|
Feb 15, 2022 |
|
Titans of Transplant: Dr. Mary Horowitz
|
Jan 24, 2022 |
|
A Deep Dive On Early Time-to-Toci
|
Jul 29, 2021 |
|
Advancements in Immunotherapies with Dr. DiPersio
|
Jun 10, 2021 |
|
Outpatient Haploidentical Stem Cell Transplantation
|
May 25, 2021 |
|
A Deep Dive on Chronic GVHD
|
Mar 24, 2021 |
|
The Role of MRD in Multiple Myeloma
|
Dec 10, 2020 |
|
MRD Negativity and Lenalidomide Maintenance Therapy: The Possible Next Chapter in Multiple Myeloma Care
|
Dec 02, 2020 |
|
Dr. Lia Gore Discusses Bispecific T-Cell Engagers in Pediatric ALL Research
|
Nov 12, 2020 |